Influx Healthtech Limited (INFLUX)
Influx Healthtech reported Q4 FY26 operational performance driven by year-on-year growth and expanded manufacturing capacity. The company invested over ₹5 crores in capex, funded internally, to enhance production capabilities and incorporated OLAHEY WELLNESS PVT LTD, a 100% subsidiary, for B2C market entry.
Apr 21 2026 15:04:00
Influx Healthtech Limited (INFLUX)
Influx Healthtech Ltd. issued a corrigendum to its April 1, 2026 postal ballot notice. The company appointed Mr. Nayan P. Pitroda as the new scrutinizer for the e-voting process, replacing M/s. Richi Prerak & Associates to ensure a fair and transparent manner.
Apr 06 2026 17:04:00
Influx Healthtech Limited (INFLUX)
Influx Healthtech dispatched Postal Ballot Notice to members. The notice covers two special resolutions for member approval. E-voting will commence on April 2, 2026, and conclude on May 1, 2026.
Apr 02 2026 17:04:00
Influx Healthtech Limited (INFLUX)
Influx Healthtech reallocated ₹10.09 crore of IPO proceeds to fund increased construction costs for Plot No. 59, now estimated at ₹17.96 crore. This reallocation is due to design revisions and input cost escalation, with funds sourced from optimized allocations for Plot No. 28 and machinery procurement.
Apr 02 2026 17:04:00
Influx Healthtech Limited (INFLUX)
Influx Healthtech is conducting a postal ballot to seek approval for two key resolutions. These include a special resolution to alter the objects of its Initial Public Offer and another for the appointment of Mr. Mohmad Saleh Mutvalli as an Independent Director for a 5-year term starting March 31, 2026.
Apr 01 2026 17:04:00
Influx Healthtech Limited (INFLUX)
Influx Healthtech is seeking shareholder approval via postal ballot to reallocate ₹1,009.31 Lakhs from its IPO proceeds. These funds will cover increased construction costs for Plot No. 59, which rose to ₹1,796.37 Lakhs. The company also proposes appointing Mr. Mohmad Saleh Mutvalli as an Independent Director for a five-year term.
Apr 01 2026 17:04:00
Influx Healthtech Limited (INFLUX)
Influx Healthtech appointed Mohmad Saleh Mutvalli as a Non-Executive Independent Director and Pitroda Nayan & Co. as the Secretarial Auditor, with both appointments effective March 31, 2026. Mr. Mutvalli is a Chartered Accountant with over 13 years of experience.
Mar 31 2026 16:03:00
Influx Healthtech Limited (INFLUX)
Influx Healthtech's board approved altering IPO objects, appointing a new Secretarial Auditor, and Mr. Mohmad Saleh Mutvalli as Additional Director. They also reconstituted the Audit, Nomination & Remuneration, and Corporate Social Responsibility Committees, effective March 31, 2026.
Mar 31 2026 16:03:00
Influx Healthtech Limited (INFLUX)
Influx Healthtech's board approved altering IPO objects, appointing a new Secretarial Auditor, and Mr. Mohmad Saleh Mutvalli as Additional Director. They also reconstituted the Audit, Nomination & Remuneration, and Corporate Social Responsibility Committees, effective March 31, 2026.
Mar 31 2026 16:03:00
Influx Healthtech Limited (INFLUX)
Influx Healthtech's board approved altering IPO objects, appointing a new Secretarial Auditor, and Mr. Mohmad Saleh Mutvalli as Additional Director. They also reconstituted the Audit, Nomination & Remuneration, and Corporate Social Responsibility Committees, effective March 31, 2026.
Mar 31 2026 16:03:00
Read More
